Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitus
Journal of Clinical Pharmacy and Therapeutics · 2022-07 · 47 (7) · 1028-1035
DOI: 10.1111/jcpt.13640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 07.03.2022. Verfasst von Miyoung Ock und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Sookmyung Women's University, Seoul, South Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fractures, Bone, Osteoporosis, Thiazolidinediones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Sookmyung Women's University, Seoul, South Korea.
- Drug Information Research Institute, Sookmyung Women's University, Seoul, South Korea.
ORCID-Profile: Hyunah Kim
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Ock, M., Lee, S., & Kim, H. (2022). Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics, 47(7), 1028-1035. https://doi.org/10.1111/jcpt.13640
Vancouver
Ock M, Lee S, Kim H. Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitus. Journal of Clinical Pharmacy and Therapeutics. 2022;47(7):1028-1035. doi:10.1111/jcpt.13640
BibTeX
@article{Ock2022,
author = {Ock, Miyoung and Lee, Sera and Kim, Hyunah},
title = {Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitus},
journal = {Journal of Clinical Pharmacy and Therapeutics},
year = {2022},
volume = {47},
number = {7},
pages = {1028--1035},
doi = {10.1111/jcpt.13640}
}
EUVIMED